Meet...

Graeme Ladds

Presenter

Graeme Ladds, Director of PharSafer, has over 30 years’ experience in the pharmaceutical industry. He began his career in 1989 at Ashbourne Pharmaceuticals as Head of Drug Safety & Medical Information, before going on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.

He later founded his consultancy and specialist CRO, PharSafer Associates Ltd, where he has supported companies in establishing pharmacovigilance systems, conducting audits across Europe and the USA, developing SOPs, acting as a QP, and supporting regulatory inspections.

Since 1994, Graeme has also been involved in the monitoring of medical devices, including drug–device combinations, structural devices and electrical medical devices. His experience spans clinical trials and global device vigilance, alongside pharmacovigilance activities across both clinical development and post-marketing phases.

Graeme Ladds’s courses

  • 30 Sep • 2 day course

Signal Detection and Regulatory Expectations

Live online

  • 08 Oct • 2 day course

Pharmacovigilance QMS & Inspection Preparation

Live online

  • 14 Oct • 1 day course

An Introduction to Signal Detection

New for 2026

Live online

  • 19 Oct • 1 day course

A Practical Guide to Writing Risk Management Plans (RMPs)

Live online

  • 10 Nov • 2 day course

Literature Searching in Drug Safety

Live online

  • 16 Nov • 2 day course

Clinical & Post-Marketing Safety

New for 2026

Live online

  • 18 Nov • 1 day course

AI in Pharmacovigilance

Live online

  • 03 Dec • 1 day course

An Essential Overview of Medical Information

Live online

  • 10 Dec • 2 day course

Cosmetovigilance

Live online

  • 10 Dec • 2 day course

Pharmacovigilance Aspects of Licensing Agreements

Live online

Reviews for Graeme’s courses

Overall, this training increased my confidence in managing SDEAs. This was confirmed by the workshop at the end.

25 Jun 2026

Pharmacovigilance Aspects of Licensing Agreements

I was hoping to better understand the application of AI in ICSR processing and signal detection activities. This was not only achieved but exceeded my expectations. I have gained a deeper understanding of how AI-based systems operate, as well as the regulations that will be implemented for AI based systems. I learned what inspectors and auditors are likely to focus on during inspections involving AI-based systems, including the types of questions they may ask and the documentation or evidence they will expect for activities supported by AI.

18 May 2026

AI in Pharmacovigilance

Speaker was very knowledgeable and clear, also great knowledge of industry examples of certain topics discussed.

11 May 2026

Clinical & Post-Marketing Safety

The webinar offered me a global vision of PV with obligations. It was a really nice summary. Very experienced speaker

30 Apr 2026

Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection

Very good on given the whole picture of the pharmacovigilance process, also very clear in his exposition of the topic

23 Mar 2026

Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider

Very useful education, great and experienced speaker who answers the questions, finds examples from practice and pace of talking makes it really easy to follow.

4 Dec 2025

An Essential Overview of Medical Information

Very useful for my daily work, very interesting and informative! A must have workshop for deeper understanding in medical information.

4 Dec 2025

An Essential Overview of Medical Information

Overall, the webinar covered what I was looking for.

3 Dec 2025

Additional Risk Minimization Measures (aRMMs) and Their Effectiveness

It was a excellent training program and I recalled liked the way Mr. Graeme Ladds has delivered the topic in a more systematic way from the introduction of the topic and then towards the ways reasons for the implementation of RMMs to promote and enable patient safety along with the live examples for various medicinal products that's required RMMs.

3 Dec 2025

Additional Risk Minimization Measures (aRMMs) and Their Effectiveness